Loading clinical trials...
Loading clinical trials...
Conditions
Locations
5
United States
University of Colorado Cancer Center
Denver, Colorado, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
MD Anderson Cancer Center
Houston, Texas, United States
Start Date
June 4, 2018
Primary Completion Date
September 2, 2021
Completion Date
September 2, 2021
Last Updated
March 7, 2024
NCT03099681
NCT05407441
NCT05415098
NCT00346164
NCT01614795
NCT00245102
Lead Sponsor
Epizyme, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions